Glaxosmithkline Pharmaceuticals consolidated net profit rises 12.44% in the June 2025 quarter
Sales decline 1.16% to Rs 805.17 crore
Net profit of Glaxosmithkline Pharmaceuticals rose 12.44% to Rs 205.01 crore in the quarter ended June 2025 as against Rs 182.33 crore during the previous quarter ended June 2024. Sales declined 1.16% to Rs 805.17 crore in the quarter ended June 2025 as against Rs 814.65 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales805.17814.65 -1 OPM %31.2028.30 -PBDT294.50265.81 11 PBT278.98249.40 12 NP205.01182.33 12Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 01 2025 | 12:53 PM IST